Alnylam Pharmaceuticals Inc (ALNY)
ETFs that hold Alnylam Pharmaceuticals Inc (ALNY)
Alnylam Pharmaceuticals Inc is held by 22 ETFs tracked in our database. The largest position is held by IBB (2.11%), a sector fund. The remaining funds hold it at 1.30% or less. The largest holders are mostly sector and factor funds.
ETFs holding Alnylam Pharmaceuticals Inc (ALNY) in our database, ranked by portfolio weight.
Which ETFs hold Alnylam Pharmaceuticals Inc (ALNY)?
The ETFs with the largest positions in Alnylam Pharmaceuticals Inc (ALNY) are: iShares Biotechnology ETF (IBB, 2.11%); SPDR S&P Biotech ETF (XBI, 1.30%); Vanguard Health Care ETF (VHT, 0.46%); iShares MSCI USA Min Vol Factor ETF (USMV, 0.35%); Vanguard Mid-Cap ETF (VO, 0.33%). The full list, ranked by weight, is in the table.
How many ETFs hold Alnylam Pharmaceuticals Inc (ALNY)?
Alnylam Pharmaceuticals Inc (ALNY) is held by 22 ETFs tracked in our database. The largest position is in IBB, where it makes up 2.11% of the fund's assets.
What does the ETF weight mean?
The weight is the share of a fund's assets invested in the stock. It shows how much passive index-fund ownership the stock has and where it carries the most influence. IBB holds Alnylam Pharmaceuticals Inc (ALNY) at 2.11%, and the simple average weight across the 22 funds is 0.27%.